71 related articles for article (PubMed ID: 9219608)
21. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
Khroyan TV; Barrett-Larimore RL; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Aug; 294(2):680-7. PubMed ID: 10900248
[TBL] [Abstract][Full Text] [Related]
22. Dopamine D1 stimulation of Na+,K+,Cl- cotransport in human NPE cells: effects of multiple hormones.
Riese K; Beyer AT; Lui GM; Crook RB
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1444-52. PubMed ID: 9660493
[TBL] [Abstract][Full Text] [Related]
23. Effects of dopamine on ATP-sensitive potassium channels in porcine coronary artery smooth-muscle cells.
Kawano H; Kawano T; Tanaka K; Eguchi S; Takahashi A; Nakaya Y; Oshita S
J Cardiovasc Pharmacol; 2008 Feb; 51(2):196-201. PubMed ID: 18287888
[TBL] [Abstract][Full Text] [Related]
24. Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.
Schurad B; Horowski R; Jähnichen S; Görnemann T; Tack J; Pertz HH
Life Sci; 2006 Apr; 78(20):2358-64. PubMed ID: 16310806
[TBL] [Abstract][Full Text] [Related]
25. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
26. Effects of the intravitreal administration of dopaminergic ligands on the b-wave amplitude of the rabbit electroretinogram.
Huppé-Gourgues F; Coudé G; Lachapelle P; Casanova C
Vision Res; 2005 Jan; 45(2):137-45. PubMed ID: 15581915
[TBL] [Abstract][Full Text] [Related]
27. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
Pickel VM; Colago EE; Mania I; Molosh AI; Rainnie DG
Neuroscience; 2006 Oct; 142(3):671-90. PubMed ID: 16905271
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic regulation of orexin neurons.
Bubser M; Fadel JR; Jackson LL; Meador-Woodruff JH; Jing D; Deutch AY
Eur J Neurosci; 2005 Jun; 21(11):2993-3001. PubMed ID: 15978010
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
Sasaki T; Kotera J; Omori K
J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
[TBL] [Abstract][Full Text] [Related]
31. Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips.
d'Emmanuele di Villa Bianca R; Sorrentino R; Roviezzo F; Imbimbo C; Palmieri A; De Dominicis G; Montorsi F; Cirino G; Mirone V
Int J Impot Res; 2005; 17(2):127-33. PubMed ID: 15549138
[TBL] [Abstract][Full Text] [Related]
32. Dopamine stimulation of cardiac beta-adrenoceptors: the involvement of sympathetic amine transporters and the effect of SKF38393.
Habuchi Y; Tanaka H; Nishio M; Yamamoto T; Komori T; Morikawa J; Yoshimura M
Br J Pharmacol; 1997 Dec; 122(8):1669-78. PubMed ID: 9422813
[TBL] [Abstract][Full Text] [Related]
33. [Effect of intrathecal injection of dopamine receptor agonists/antagonists on pain and acupuncture analgesia in rats].
Gao X; Xin BM; Zhu CB; Wu GC; Xu SF
Sheng Li Xue Bao; 1998 Feb; 50(1):43-8. PubMed ID: 11324516
[TBL] [Abstract][Full Text] [Related]
34. The effects of dopamine agonists and antagonists on the secretory responses in the salivary glands of the locust (Locusta migratoria).
Keating C; Orchard I
J Insect Physiol; 2004 Jan; 50(1):17-23. PubMed ID: 15037089
[TBL] [Abstract][Full Text] [Related]
35. The dopaminergic system in the periphery.
Schwartz J
J Pharmacol; 1984; 15(4):401-14. PubMed ID: 6098788
[TBL] [Abstract][Full Text] [Related]
36. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
37. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension.
Murphy MB; Murray C; Shorten GD
N Engl J Med; 2001 Nov; 345(21):1548-57. PubMed ID: 11794223
[No Abstract] [Full Text] [Related]
38. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
39. [Effects of dopexamine on the electrophysiologic changes during myocardial ischemia and comparison with fenoldopam and procaterol].
Qin FZ; Zhao RR; Zhu L; Wang WZ; Wu BW
Yao Xue Xue Bao; 1995; 30(3):161-7. PubMed ID: 7639078
[TBL] [Abstract][Full Text] [Related]
40. The dopamine receptor agonist Z1046 reduces ischaemia severity in a canine model of coronary artery occlusion.
Végh A; Papp JG; Semeraro C; Fatehi-Hasanabad Z; Parratt JR
Eur J Pharmacol; 1998 Mar; 344(2-3):203-13. PubMed ID: 9600656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
